Literature DB >> 16303324

Human cytidine deaminase: a three-dimensional homology model of a tetrameric metallo-enzyme inferred from the crystal structure of a distantly related dimeric homologue.

Stefano Costanzi1, Silvia Vincenzetti, Gloria Cristalli, Alberto Vita.   

Abstract

Cytidine deaminase (CDA) is a cytosolic metalloprotein whose functional unit can be either a homotetramer (T-CDA) or a homodimer (D-CDA), depending on the species. In 1994, the first crystal structure of the dimeric Escherichia coli CDA has been published. However, a crystal structure of a tetrameric CDA was not determined until 2002. Prior to the disclosure of the experimentally elucidated structure of a tetrameric CDA, we derived a homology model of the human T-CDA employing the crystal structure of the dimeric E. coli CDA as a template. The comparison of our theoretical model with the crystal structure of the human T-CDA, subsequently published in 2004, validates our prediction: not only of the structural features of the monomer and the details of the binding site, but also the multimeric arrangement of the subunits were determined with high accuracy in our model. By means of a phylogenetic analysis conducted on CDAs from various organisms, we demonstrate that the E. coli CDA is one of the furthest known homologues of the human enzyme. Nonetheless, despite the evolutionary distance and, more importantly, the different multimeric arrangement of their functional units, the E. coli CDA proved to have all the necessary information to accurately infer the structure of its human homologue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16303324     DOI: 10.1016/j.jmgm.2005.10.008

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  7 in total

1.  Human P2Y(6) receptor: molecular modeling leads to the rational design of a novel agonist based on a unique conformational preference.

Authors:  Stefano Costanzi; Bhalchandra V Joshi; Savitri Maddileti; Liaman Mamedova; Maria J Gonzalez-Moa; Victor E Marquez; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2005-12-29       Impact factor: 7.446

2.  Creation of zebularine-resistant human cytidine deaminase mutants to enhance the chemoprotection of hematopoietic stem cells.

Authors:  Hongmei Ruan; Songbo Qiu; Brian C Beard; Margaret E Black
Journal:  Protein Eng Des Sel       Date:  2016-05-08       Impact factor: 1.650

3.  Delineation of the molecular mechanisms of nucleoside recognition by cytidine deaminase through virtual screening.

Authors:  Stefano Costanzi; Santiago Vilar; Daniela Micozzi; Francesco M Carpi; Giulio Ferino; Alberto Vita; Silvia Vincenzetti
Journal:  ChemMedChem       Date:  2011-05-19       Impact factor: 3.466

4.  Role of tyrosine 33 residue for the stabilization of the tetrameric structure of human cytidine deaminase.

Authors:  Daniela Micozzi; Stefania Pucciarelli; Francesco M Carpi; Stefano Costanzi; Giampiero De Sanctis; Valeria Polzonetti; Paolo Natalini; Ivano F Santarelli; Alberto Vita; Silvia Vincenzetti
Journal:  Int J Biol Macromol       Date:  2010-07-14       Impact factor: 6.953

5.  On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor.

Authors:  Stefano Costanzi
Journal:  J Med Chem       Date:  2008-04-29       Impact factor: 7.446

Review 6.  The current toolbox for APOBEC drug discovery.

Authors:  Michael J Grillo; Katherine F M Jones; Michael A Carpenter; Reuben S Harris; Daniel A Harki
Journal:  Trends Pharmacol Sci       Date:  2022-05       Impact factor: 17.638

7.  Plasma metabolomic profiling of proliferative diabetic retinopathy.

Authors:  Xiao-Rong Zhu; Fang-Yuan Yang; Jing Lu; Hui-Rong Zhang; Ran Sun; Jian-Bo Zhou; Jin-Kui Yang
Journal:  Nutr Metab (Lond)       Date:  2019-05-28       Impact factor: 4.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.